Goldline Pharmaceutical closes trading window ahead of financial results review Back
<p>Goldline Pharmaceutical Limited informed the Bombay Stock Exchange that the trading window for its securities will be closed from October 1, 2026, for designated persons and their immediate relatives, pending consideration of the company’s unaudited financial results for the half year ended September 30, 2026, with the board meeting date to be announced separately.</p>